UCHL1 Antikörper (N-Term)

Produktnummer ABIN544860

Produktdetails anti-UCHL1 Antikörper

Target: UCHL1 (Ubiquitin Carboxyl-terminal Esterase L1 (Ubiquitin Thiolesterase) (UCHL1))

Bindungsspezifität: N-Term

Reaktivität: Human, Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser UCHL1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Flow Cytometry (FACS)

Verwendungszweck: Rabbit polyclonal antibody raised against synthetic peptide of UCHL1.

Kreuzreaktivität: Human, Maus

Immunogen: A synthetic peptide (conjugated with KLH) corresponding to N-terminus of human UCHL1.

Anwendungsinformationen

Applikationshinweise: Flow Cytometry (1:10-50)
Immunofluorescence (1:10-50)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (1:10-50)
Western Blot (1:1000)
The optimal working dilution should be determined by the end user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: In PBS (0.09 % sodium azide)

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.

Referenzen für anti-UCHL1 Antikörper (ABIN544860)

Jin, Yu, Lou, Zhou, Han, Zhao, Lin: "UCHL1 Is a Putative Tumor Suppressor in Ovarian Cancer Cells and Contributes to Cisplatin Resistance." in: Journal of Cancer, Vol. 4, Issue 8, pp. 662-70, (2013) (PubMed).

Nishikawa, Li, Kawamura, Osaka, Wang, Hara, Hirokawa, Manago, Amano, Noda, Aoki, Wada: "Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants." in: Biochemical and biophysical research communications, Vol. 304, Issue 1, pp. 176-83, (2003) (PubMed).

Maraganore, de Andrade, Lesnick, Farrer, Bower, Hardy, Rocca: "Complex interactions in Parkinson's disease: a two-phased approach." in: Movement disorders : official journal of the Movement Disorder Society, Vol. 18, Issue 6, pp. 631-6, (2003) (PubMed).

Liu, Fallon, Lashuel, Liu, Lansbury: "The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility." in: Cell, Vol. 111, Issue 2, pp. 209-18, (2002) (PubMed).

Details zu UCHL1

Target: UCHL1 (Ubiquitin Carboxyl-terminal Esterase L1 (Ubiquitin Thiolesterase) (UCHL1))

Andere Bezeichnung: UCHL1 / PGP9.5 (UCHL1 Produkte)

Synonyme: PARK5 antikoerper, PGP 9.5 antikoerper, PGP9.5 antikoerper, PGP95 antikoerper, Uch-L1 antikoerper, UCH-L1 antikoerper, UCHL1 antikoerper, cb358 antikoerper, wu:fc55h08 antikoerper, park5 antikoerper, pgp9.5 antikoerper, uch-l1 antikoerper, MGC132191 antikoerper, uchl1 antikoerper, AW822034 antikoerper, C88048 antikoerper, R75593 antikoerper, UCHL-1 antikoerper, gad antikoerper, ubiquitin C-terminal hydrolase L1 antikoerper, ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) antikoerper, ubiquitin C-terminal hydrolase L1 L homeolog antikoerper, ubiquitin carboxyl-terminal esterase L1 antikoerper, ubiquitin carboxy-terminal hydrolase L1 antikoerper, UCHL1 antikoerper, uchl1 antikoerper, uchl1.L antikoerper, LOC100304750 antikoerper, Uchl1 antikoerper

Gen-ID: 7345

Pathways: Feeding Behaviour